320 related articles for article (PubMed ID: 16876274)
1. A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy.
Muren LP; Redpath AT; McLaren D; Rørvik J; Halvorsen OJ; Høstmark J; Bakke A; Thwaites D; Dahl O
Radiother Oncol; 2006 Jul; 80(1):98-105. PubMed ID: 16876274
[TBL] [Abstract][Full Text] [Related]
2. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
[TBL] [Abstract][Full Text] [Related]
4. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
[TBL] [Abstract][Full Text] [Related]
5. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
6. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
Stewart AJ; Lee YK; Saran FH
Radiother Oncol; 2009 Oct; 93(1):125-30. PubMed ID: 19604591
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
[TBL] [Abstract][Full Text] [Related]
8. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
10. Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer.
Muren LP; Redpath AT; McLaren DB
Radiother Oncol; 2004 Apr; 71(1):65-71. PubMed ID: 15066297
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
12. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
14. Assessment of extended-field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy.
Lian J; Mackenzie M; Joseph K; Pervez N; Dundas G; Urtasun R; Pearcey R
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):935-43. PubMed ID: 18164828
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
16. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
Vargas C; Fryer A; Mahajan C; Indelicato D; Horne D; Chellini A; McKenzie C; Lawlor P; Henderson R; Li Z; Lin L; Olivier K; Keole S
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):744-51. PubMed ID: 17904306
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
[TBL] [Abstract][Full Text] [Related]
18. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.
Knab B; Rash C; Farrey K; Jani AB
Med Dosim; 2006; 31(4):292-7. PubMed ID: 17134669
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]